Literature DB >> 172752

Cyclic nucleotides in disease; on the biochemical etiology of hypertension.

M S Amer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 172752     DOI： 10.1016/0024-3205(75)90321-5

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

1.  Regulation of guanylate and adenylate cyclase activities by lysolecithin.

Authors:  W T Shier; J H Baldwin; M Nilsen-Hamilton; R T Hamilton; N M Thanassi
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  Evolution of aortic and cardiac cyclic AMP phosphodiesterase during the onset of mineralpcorticoid hypertension in the rat [proceedings].

Authors:  C Lugnier; T Michon; J C Stoclet
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

3.  Central tyramine prevents hypertension in uninephrectomized DOCA-saline treated rats.

Authors:  B Shalita; S Dikstein
Journal:  Experientia       Date:  1977-11-15

4.  d-Tyrosine prevents hypertension in DOCA-saline treated uninephrectomised rats.

Authors:  B Shalita; S Dikstein
Journal:  Pflugers Arch       Date:  1979-04-30       Impact factor: 3.657

5.  Thermal trauma alters myocardial cyclic nucleotides and protein content in mice.

Authors:  J F Tomera; J A Martyn
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

6.  Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats. Relationship to adenylate cyclase inhibition.

Authors:  M B Anand-Srivastava
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

7.  Conformational basis for the activation of adenylate cyclase by adenosine.

Authors:  D L Miles; D W Miles; H Eyring
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.